CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-03-18 | Aryeh Jason Director | Sale | −6,381 | $5.96 | $38K | 352,820 |
| 2010-03-18 | Aryeh Jason Director | Sale | −200 | $5.97 | $1K | 352,620 |
| 2010-03-17 | Aryeh Jason Director | Sale | −8,800 | $5.94 | $52K | 361,820 |
| 2010-03-17 | Aryeh Jason Director | Sale | −2,619 | $5.96 | $16K | 359,201 |
| 2010-03-17 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Sale | −9,873 | $5.93 | $59K | 29,650.1 |
| 2010-03-15 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Grant or award · Stock Option (right to buy) | +1,000 | 1,000 | ||
| 2010-03-15 | Aryeh Jason Director | Sale | −200 | $5.93 | $1K | 370,620 |
| 2010-03-12 | Aryeh Jason Director | Sale | −600 | $5.93 | $4K | 386,820 |
| 2010-03-12 | Aryeh Jason Director | Sale | −16,000 | $5.93 | $95K | 370,820 |
| 2010-03-11 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Exercise or conversion | +1,125 | $3.95 | $4K | 40,648.1 |
| 2010-03-11 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Sale | −1,125 | $5.95 | $7K | 39,523.1 |
| 2010-03-11 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Exercise or conversion · Stock Option (Right to Buy) | −1,125 | 14,625 | ||
| 2010-03-11 | Aryeh Jason Director | Sale | −180,700 | $5.88 | $1.1M | 387,420 |
| 2010-03-10 | Aryeh Jason Director | Sale | −16,100 | $5.74 | $92K | 568,120 |
| 2010-03-08 | Aryeh Jason Director | Sale | −3,200 | $5.75 | $18K | 584,220 |
| 2010-03-02 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Exercise or conversion | +2,250 | $3.95 | $9K | 41,773.1 |
| 2010-03-02 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Sale | −2,250 | $5.45 | $12K | 39,523.1 |
| 2010-03-02 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Exercise or conversion · Stock Option (Right to Buy) | −2,250 | 15,750 | ||
| 2010-01-13 | Aryeh Jason Director | Sale | −13,800 | $5.49 | $76K | 587,420 |
| 2010-01-12 | Aryeh Jason Director | Sale | −86,200 | $5.49 | $473K | 601,220 |
Page 31 of 42 · 830 trades